21 – 30 of 128
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
- Contribution to journal › Article
-
Mark
Treating schizophrenia with cariprazine : From clinical research to clinical practice. Real world experiences and recommendations from an International Panel
- Contribution to journal › Scientific review
-
Mark
Virtual reality based cognitive behavioral therapy for paranoia : Effects on mental states and the dynamics among them
- Contribution to journal › Article
- 2019
-
Mark
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis
- Contribution to journal › Letter
-
Mark
FAST-O works well for characterization and monitoring of sheltered housing schizophrenia patients
- Contribution to journal › Article
-
Mark
Magnetic Resonance Spectroscopy in Schizophrenia : Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
- Contribution to journal › Article
- 2018
-
Mark
Occupational engagement and cognitive functioning among persons with schizophrenia: en explorative study
- Contribution to journal › Article
-
Mark
Psychopathological Symptoms and Satisfaction with Mental Health in Patients with Schizophrenia
- Contribution to journal › Article
-
Mark
The effect of schizophrenia on length of in-hospital stay and major adverse cardiac events following acute coronary syndrome in Denmark
- Contribution to journal › Published meeting abstract
-
Mark
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
- Contribution to journal › Article
